At a glance
ClinicalIndex Comparison RecordN/ACompleted· 48 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Calcium polycarbophil 625 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study
In Brief
A clinical study evaluating Placebo and Calcium polycarbophil for Diabetes Mellitus Type II. Completed, enrolled 48 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether a form of fiber if effective in improving the treatment of type 2 diabetes. Measurements of other possible medical benefits will include blood pressure, cholesterol, weight, and the number/dosage of medications used for diabetes, hypertension, and high cholesterol.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus Type II
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
First PostedDec 2010
Primary CompletionApr 2011
TodayJul 2026
First PostedDec 3, 2010
Enrollment StartOct 1, 2010
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 15.6 years ago
Interventions
Placebodrug
Placebo tablet po TID before each meal with 8 oz of water for 6 months
Calcium polycarbophildrug
calcium polycarbophil 625 mg po TID before each meal with 8 oz water for 6 months